Flow cytometric analysis showed that all the NSCLC cell lines robustly expressed CD44, whereas the only SCLC cell line, SHP-77, failed to show any detectable CD44 expression (Fig. 5A). The gene discussed is CD44; the disease is non-small cell lung carcinoma.